Cargando…
COVID-19 impact on the decision process of the Italian Medicine Agency: a quantitative assessment
BACKGROUND: Since the COVID-19 pandemic has placed more attention on drugs’ approval process and the importance of rapid decision-making in the healthcare sector, it is crucial to assess how time to market (TTM) of drugs varied. OBJECTIVE: To estimate the impact of the COVID-19 pandemic on TTM of dr...
Autores principales: | Canali, Beatrice, Candelora, Laura, Fiorentino, Francesca, Halmos, Tom, La Malfa, Paola, Massara, Francesca, Vassallo, Chiara, Urbinati, Duccio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AboutScience
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238912/ https://www.ncbi.nlm.nih.gov/pubmed/37275270 http://dx.doi.org/10.33393/grhta.2023.2560 |
Ejemplares similares
-
HPR108 Impact of COVID-19 Pandemic on the Decision Process of the Italian Medicine Agency: A Quantitative Assessment
por: Fiorentino, F, et al.
Publicado: (2022) -
Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2021) -
Pharmacovigilance and the Italian Medicines Agency
por: Pimpinella, Giuseppe, et al.
Publicado: (2013) -
Intellectual disability: an Italian perspective
por: La Malfa, Giampaolo, et al.
Publicado: (2007) -
Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)